ID   K1C9_HUMAN              Reviewed;         623 AA.
AC   P35527; O00109; Q0IJ47; Q14665;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   16-JUN-2009, sequence version 3.
DT   28-JUN-2023, entry version 215.
DE   RecName: Full=Keratin, type I cytoskeletal 9;
DE   AltName: Full=Cytokeratin-9;
DE            Short=CK-9;
DE   AltName: Full=Keratin-9;
DE            Short=K9;
GN   Name=KRT9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, FUNCTION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Foot sole tissue;
RX   PubMed=7507869; DOI=10.1111/j.1432-0436.1993.tb00033.x;
RA   Langbein L., Heid H.W., Moll I., Franke W.W.;
RT   "Molecular characterization of the body site-specific human epidermal
RT   cytokeratin 9: cDNA cloning, amino acid sequence, and tissue specificity of
RT   gene expression.";
RL   Differentiation 55:57-72(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS EPPK LYS-161; GLN-163 AND
RP   TRP-163.
RX   PubMed=7512862; DOI=10.1038/ng0294-174;
RA   Reis A., Hennies H.-C., Langbein L., Digweed M., Mischke D., Dreschler M.,
RA   Schroek E., Royer-Pokora B., Franke W.W., Sperling K., Kuester W.;
RT   "Keratin 9 gene mutations in epidermolytic palmoplantar keratoderma
RT   (EPPK).";
RL   Nat. Genet. 6:174-179(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [4]
RP   PROTEIN SEQUENCE OF 14-29, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RA   Bienvenut W.V.;
RL   Submitted (AUG-2005) to UniProtKB.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 147-372, AND VARIANT EPPK GLN-163.
RX   PubMed=8647270; DOI=10.1016/0014-5793(96)00393-6;
RA   Kobayashi S., Tanaka T., Matsuyoshi N., Imamura S.;
RT   "Keratin 9 point mutation in the pedigree of epidermolytic hereditary
RT   palmoplantar keratoderma perturbs keratin intermediate filament network
RT   formation.";
RL   FEBS Lett. 386:149-155(1996).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 157-623.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 450-466.
RX   PubMed=2140676; DOI=10.1016/0006-291x(90)91140-n;
RA   Rosen E.M., Meromsky L., Romero R., Setter E., Goldberg I.;
RT   "Human placenta contains an epithelial scatter protein.";
RL   Biochem. Biophys. Res. Commun. 168:1082-1088(1990).
RN   [8]
RP   FUNCTION, AND MUTAGENESIS OF ARG-163.
RX   PubMed=10218578; DOI=10.1016/s0014-5793(99)00233-1;
RA   Kobayashi S., Kore-eda S., Tanaka T.;
RT   "Demonstration of the pathogenic effect of point mutated keratin 9 in
RT   vivo.";
RL   FEBS Lett. 447:39-43(1999).
RN   [9]
RP   INDUCTION.
RX   PubMed=10201533; DOI=10.1046/j.1523-1747.1999.00544.x;
RA   Yamaguchi Y., Itami S., Tarutani M., Hosokawa K., Miura H., Yoshikawa K.;
RT   "Regulation of keratin 9 in nonpalmoplantar keratinocytes by palmoplantar
RT   fibroblasts through epithelial-mesenchymal interactions.";
RL   J. Invest. Dermatol. 112:483-488(1999).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [15]
RP   VARIANTS EPPK VAL-157 AND PRO-172.
RX   PubMed=7516304; DOI=10.1007/bf00201564;
RA   Hennies H.-C., Zehender D., Kunze J., Kuester W., Reis A.;
RT   "Keratin 9 gene mutational heterogeneity in patients with epidermolytic
RT   palmoplantar keratoderma.";
RL   Hum. Genet. 93:649-654(1994).
RN   [16]
RP   VARIANT EPPK SER-161.
RX   PubMed=7523529; DOI=10.1111/1523-1747.ep12395570;
RA   Bonifas J.M., Matsumura K., Chen M.A., Berth-Jones J., Hutchinson P.E.,
RA   Zloczower M., Fritsch P.O., Epstein E.H. Jr.;
RT   "Mutations of keratin 9 in two families with palmoplantar epidermolytic
RT   hyperkeratosis.";
RL   J. Invest. Dermatol. 103:474-477(1994).
RN   [17]
RP   VARIANT EPPK TYR-161.
RX   PubMed=7511021; DOI=10.1038/ng0194-106;
RA   Torchard D., Blanchet-Bardon C., Serova O., Langbein L., Narod S.,
RA   Janin N., Goguel A.F., Bernheim A., Franke W.W., Lenoir G.M., Feunteun J.;
RT   "Epidermolytic palmoplantar keratoderma cosegregates with a keratin 9
RT   mutation in a pedigree with breast and ovarian cancer.";
RL   Nat. Genet. 6:106-110(1994).
RN   [18]
RP   VARIANTS EPPK TRP-163 AND SER-168.
RX   PubMed=7532199; DOI=10.1111/1523-1747.ep12666018;
RA   Rothnagel J.A., Wojcik S., Liefer K.M., Dominey A.M., Huber M., Hohl D.,
RA   Roop D.R.;
RT   "Mutations in the 1A domain of keratin 9 in patients with epidermolytic
RT   palmoplantar keratoderma.";
RL   J. Invest. Dermatol. 104:430-433(1995).
RN   [19]
RP   VARIANT EPPK VAL-160.
RX   PubMed=9204965; DOI=10.1111/1523-1747.ep12276751;
RA   Endo H., Hatamochi A., Shinkai H.;
RT   "A novel mutation of a leucine residue in coil 1A of keratin 9 in
RT   epidermolytic palmoplantar keratoderma.";
RL   J. Invest. Dermatol. 109:113-115(1997).
RN   [20]
RP   VARIANTS EPPK THR-157; VAL-157 AND GLN-163.
RX   PubMed=9856842; DOI=10.1046/j.1523-1747.1998.00445.x;
RA   Covello S.P., Irvine A.D., McKenna K.E., Munro C.S., Nevin N.C.,
RA   Smith F.J.D., Uitto J., McLean W.H.I.;
RT   "Mutations in keratin K9 in kindreds with epidermolytic palmoplantar
RT   keratoderma and epidemiology in Northern Ireland.";
RL   J. Invest. Dermatol. 111:1207-1209(1998).
RN   [21]
RP   VARIANTS EPPK GLN-163 AND STOP-170.
RX   PubMed=10632938; DOI=10.1046/j.1525-1470.1999.00111.x;
RA   Szalai S., Szalai C., Becker K., Torok E.;
RT   "Keratin 9 mutations in the coil 1A region in epidermolytic palmoplantar
RT   keratoderma.";
RL   Pediatr. Dermatol. 16:430-435(1999).
RN   [22]
RP   VARIANT EPPK TRP-163.
RX   PubMed=10844507; DOI=10.1046/j.1365-2230.2000.00626.x;
RA   Warmuth I., Cserhalmi-Friedman P.B., Schneiderman P., Grossman M.E.,
RA   Christiano A.M.;
RT   "Epidermolytic palmoplantar keratoderma in a Hispanic kindred resulting
RT   from a mutation in the keratin 9 gene.";
RL   Clin. Exp. Dermatol. 25:244-246(2000).
RN   [23]
RP   VARIANT EPPK ILE-161.
RX   PubMed=12192490; DOI=10.1007/s00403-002-0328-9;
RA   Kuster W., Reis A., Hennies H.C.;
RT   "Epidermolytic palmoplantar keratoderma of Vorner: re-evaluation of
RT   Vorner's original family and identification of a novel keratin 9
RT   mutation.";
RL   Arch. Dermatol. Res. 294:268-272(2002).
RN   [24]
RP   VARIANTS EPPK VAL-157; TRP-163; GLN-163 AND MET-171.
RX   PubMed=12072061; DOI=10.1046/j.1365-2133.2002.04764.x;
RA   Rugg E.L., Common J.E., Wilgoss A., Stevens H.P., Buchan J., Leigh I.M.,
RA   Kelsell D.P.;
RT   "Diagnosis and confirmation of epidermolytic palmoplantar keratoderma by
RT   the identification of mutations in keratin 9 using denaturing high-
RT   performance liquid chromatography.";
RL   Br. J. Dermatol. 146:952-957(2002).
RN   [25]
RP   VARIANT EPPK ILE-161.
RX   PubMed=12926810; DOI=10.1080/00015550310016652;
RA   Csikos M., Hollo P., Becker K., Racz E., Horvath A., Karpati S.;
RT   "Novel N160I mutation of keratin 9 in a large pedigree from Hungary with
RT   epidermolytic palmoplantar keratoderma.";
RL   Acta Derm. Venereol. 83:303-305(2003).
RN   [26]
RP   VARIANT EPPK PHE-160.
RX   PubMed=12838553; DOI=10.1002/ajmg.a.20090;
RA   Lu Y., Guo C., Liu Q., Zhang X., Cheng L., Li J., Chen B., Gao G., Zhou H.,
RA   Guo Y., Li Y., Gong Y.;
RT   "A novel mutation of keratin 9 in epidermolytic palmoplantar keratoderma
RT   combined with knuckle pads.";
RL   Am. J. Med. Genet. A 120:345-349(2003).
RN   [27]
RP   VARIANTS EPPK HIS-161; SER-161 AND TRP-163.
RX   PubMed=14675368; DOI=10.1111/j.0906-6705.2003.00012.x;
RA   Lee J.-H., Ahn K.-S., Lee C.-H., Youn S.-J., Kim J.-W., Lee D.-Y.,
RA   Lee E.-S., Steinert P.M., Yang J.-M.;
RT   "Keratin 9 gene mutations in five Korean families with epidermolytic
RT   palmoplantar keratoderma.";
RL   Exp. Dermatol. 12:876-881(2003).
RN   [28]
RP   VARIANT EPPK TYR-167 DEL TRP-LEU INS.
RX   PubMed=15099359; DOI=10.1111/j.0007-0963.2004.05865.x;
RA   He X.-H., Zhang X.-N., Mao W., Chen H.-P., Xu L.-R., Chen H., He X.-L.,
RA   Le Y.-P.;
RT   "A novel mutation of keratin 9 in a large Chinese family with epidermolytic
RT   palmoplantar keratoderma.";
RL   Br. J. Dermatol. 150:647-651(2004).
RN   [29]
RP   VARIANT EPPK HIS-161.
RX   PubMed=15115518; DOI=10.1111/j.1365-2230.2004.01497.x;
RA   Lin J.-H., Lin M.-H., Yang M.-H., Chao S.-C.;
RT   "A novel keratin 9 gene mutation (Asn160His) in a Taiwanese family with
RT   epidermolytic palmoplantar keratoderma.";
RL   Clin. Exp. Dermatol. 29:308-310(2004).
RN   [30]
RP   VARIANT EPPK PRO-163.
RX   PubMed=15605275; DOI=10.1007/s00403-004-0534-8;
RA   Kon A., Itagaki K., Yoneda K., Takagaki K.;
RT   "A novel mutation of keratin 9 gene (R162P) in a Japanese family with
RT   epidermolytic palmoplantar keratoderma.";
RL   Arch. Dermatol. Res. 296:375-378(2005).
RN   [31]
RP   VARIANT EPPK PHE-458.
RX   PubMed=16911293; DOI=10.1111/j.1365-2133.2006.07358.x;
RA   Kon A., Ito N., Kudo Y., Nomura K., Yoneda K., Hanada K., Hashimoto I.,
RA   Takagaki K.;
RT   "L457F missense mutation within the 2B rod domain of keratin 9 in a
RT   Japanese family with epidermolytic palmoplantar keratoderma.";
RL   Br. J. Dermatol. 155:624-626(2006).
RN   [32]
RP   VARIANT EPPK ARG-157.
RX   PubMed=16961539; DOI=10.1111/j.1365-4632.2006.02910.x;
RA   Shimazu K., Tsunemi Y., Hattori N., Saeki H., Komine M., Adachi M.,
RA   Tamaki K.;
RT   "A novel keratin 9 gene mutation (Met156Arg) in a Japanese patient with
RT   epidermolytic palmoplantar keratoderma.";
RL   Int. J. Dermatol. 45:1128-1130(2006).
RN   [33]
RP   VARIANTS EPPK LYS-157; THR-157; GLN-163 AND HIS-454.
RX   PubMed=19874353; DOI=10.1111/j.1365-2230.2009.03700.x;
RA   Shimomura Y., Wajid M., Weiser J., Kraemer L., Christiano A.M.;
RT   "Mutations in the keratin 9 gene in Pakistani families with epidermolytic
RT   palmoplantar keratoderma.";
RL   Clin. Exp. Dermatol. 35:759-764(2010).
RN   [34]
RP   VARIANT EPPK ARG-406.
RX   PubMed=20964665; DOI=10.1111/j.1365-4632.2009.04295.x;
RA   Wang K., He C.D., Song F., Liu J., Chen H.D.;
RT   "A novel mutation of the keratin 9 gene in a Chinese family with
RT   epidermolytic palmoplantar keratoderma.";
RL   Int. J. Dermatol. 49:1342-1344(2010).
RN   [35]
RP   VARIANT EPPK PRO-458.
RX   PubMed=21715251; DOI=10.1684/ejd.2011.1458;
RA   Du Z.F., Wei W., Wang Y.F., Chen X.L., Chen C.Y., Liu W.T., Lu J.J.,
RA   Mao L.G., Xu C.M., Fang H., Zhang X.N.;
RT   "A novel mutation within the 2B rod domain of keratin 9 in a Chinese
RT   pedigree with epidermolytic palmoplantar keratoderma combined with knuckle
RT   pads and camptodactyly.";
RL   Eur. J. Dermatol. 21:675-679(2011).
CC   -!- FUNCTION: May serve an important special function either in the mature
CC       palmar and plantar skin tissue or in the morphogenetic program of the
CC       formation of these tissues. Plays a role in keratin filament assembly.
CC       {ECO:0000269|PubMed:10218578, ECO:0000269|PubMed:7507869}.
CC   -!- SUBUNIT: Heterotetramer of two type I and two type II keratins.
CC   -!- TISSUE SPECIFICITY: Expressed in the terminally differentiated
CC       epidermis of palms and soles. {ECO:0000269|PubMed:7507869}.
CC   -!- INDUCTION: Induced by intrinsic regulatory mechanisms and by extrinsic
CC       signals from a subset of dermal palmoplantar fibroblasts.
CC       {ECO:0000269|PubMed:10201533}.
CC   -!- DISEASE: Keratoderma, palmoplantar, epidermolytic (EPPK) [MIM:144200]:
CC       A dermatological disorder characterized by diffuse thickening of the
CC       epidermis on the entire surface of palms and soles sharply bordered
CC       with erythematous margins. Some patients may present knuckle pads,
CC       thick pads of skin appearing over the proximal phalangeal joints.
CC       {ECO:0000269|PubMed:10632938, ECO:0000269|PubMed:10844507,
CC       ECO:0000269|PubMed:12072061, ECO:0000269|PubMed:12192490,
CC       ECO:0000269|PubMed:12838553, ECO:0000269|PubMed:12926810,
CC       ECO:0000269|PubMed:14675368, ECO:0000269|PubMed:15099359,
CC       ECO:0000269|PubMed:15115518, ECO:0000269|PubMed:15605275,
CC       ECO:0000269|PubMed:16911293, ECO:0000269|PubMed:16961539,
CC       ECO:0000269|PubMed:19874353, ECO:0000269|PubMed:20964665,
CC       ECO:0000269|PubMed:21715251, ECO:0000269|PubMed:7511021,
CC       ECO:0000269|PubMed:7512862, ECO:0000269|PubMed:7516304,
CC       ECO:0000269|PubMed:7523529, ECO:0000269|PubMed:7532199,
CC       ECO:0000269|PubMed:8647270, ECO:0000269|PubMed:9204965,
CC       ECO:0000269|PubMed:9856842}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: There are two types of cytoskeletal and microfibrillar
CC       keratin, I (acidic) and II (neutral to basic) (40-55 and 56-70 kDa,
CC       respectively).
CC   -!- SIMILARITY: Belongs to the intermediate filament family.
CC       {ECO:0000255|PROSITE-ProRule:PRU01188}.
CC   -!- CAUTION: Was originally thought to be a 60 kDa chain of placental
CC       scatter protein. {ECO:0000305|PubMed:2140676}.
CC   -!- WEB RESOURCE: Name=Human Intermediate Filament Mutation Database;
CC       URL="http://www.interfil.org";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z29074; CAA82315.1; -; mRNA.
DR   EMBL; S69510; AAC60619.1; -; mRNA.
DR   EMBL; X75015; CAA52924.1; -; Genomic_DNA.
DR   EMBL; AC019349; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AB001594; BAA19418.1; -; mRNA.
DR   EMBL; BC121170; AAI21171.1; -; mRNA.
DR   CCDS; CCDS32654.1; -.
DR   PIR; I37984; I37984.
DR   RefSeq; NP_000217.2; NM_000226.3.
DR   AlphaFoldDB; P35527; -.
DR   SMR; P35527; -.
DR   BioGRID; 110055; 142.
DR   IntAct; P35527; 42.
DR   MINT; P35527; -.
DR   STRING; 9606.ENSP00000246662; -.
DR   DrugBank; DB09130; Copper.
DR   DrugBank; DB01593; Zinc.
DR   DrugBank; DB14487; Zinc acetate.
DR   DrugBank; DB14533; Zinc chloride.
DR   DrugBank; DB14548; Zinc sulfate, unspecified form.
DR   GlyConnect; 1951; 12 N-Linked glycans (2 sites).
DR   GlyCosmos; P35527; 2 sites, 12 glycans.
DR   GlyGen; P35527; 4 sites, 12 N-linked glycans (2 sites), 1 O-linked glycan (2 sites).
DR   iPTMnet; P35527; -.
DR   PhosphoSitePlus; P35527; -.
DR   SwissPalm; P35527; -.
DR   BioMuta; KRT9; -.
DR   DMDM; 239938886; -.
DR   DOSAC-COBS-2DPAGE; P35527; -.
DR   EPD; P35527; -.
DR   jPOST; P35527; -.
DR   MassIVE; P35527; -.
DR   PaxDb; P35527; -.
DR   PeptideAtlas; P35527; -.
DR   PRIDE; P35527; -.
DR   ProteomicsDB; 55077; -.
DR   TopDownProteomics; P35527; -.
DR   Antibodypedia; 1544; 239 antibodies from 28 providers.
DR   DNASU; 3857; -.
DR   Ensembl; ENST00000246662.9; ENSP00000246662.4; ENSG00000171403.10.
DR   GeneID; 3857; -.
DR   KEGG; hsa:3857; -.
DR   MANE-Select; ENST00000246662.9; ENSP00000246662.4; NM_000226.4; NP_000217.2.
DR   UCSC; uc002hxe.5; human.
DR   AGR; HGNC:6447; -.
DR   CTD; 3857; -.
DR   DisGeNET; 3857; -.
DR   GeneCards; KRT9; -.
DR   HGNC; HGNC:6447; KRT9.
DR   HPA; ENSG00000171403; Tissue enriched (lymphoid).
DR   MalaCards; KRT9; -.
DR   MIM; 144200; phenotype.
DR   MIM; 149100; phenotype.
DR   MIM; 607606; gene.
DR   neXtProt; NX_P35527; -.
DR   OpenTargets; ENSG00000171403; -.
DR   Orphanet; 2199; Epidermolytic palmoplantar keratoderma.
DR   PharmGKB; PA30235; -.
DR   VEuPathDB; HostDB:ENSG00000171403; -.
DR   eggNOG; ENOG502QTM6; Eukaryota.
DR   GeneTree; ENSGT00940000162894; -.
DR   HOGENOM; CLU_012560_8_3_1; -.
DR   InParanoid; P35527; -.
DR   OMA; HQEEMSQ; -.
DR   OrthoDB; 4640531at2759; -.
DR   PhylomeDB; P35527; -.
DR   TreeFam; TF332742; -.
DR   PathwayCommons; P35527; -.
DR   Reactome; R-HSA-6805567; Keratinization.
DR   Reactome; R-HSA-6809371; Formation of the cornified envelope.
DR   SignaLink; P35527; -.
DR   BioGRID-ORCS; 3857; 9 hits in 1141 CRISPR screens.
DR   GeneWiki; Keratin_9; -.
DR   GenomeRNAi; 3857; -.
DR   Pharos; P35527; Tbio.
DR   PRO; PR:P35527; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; P35527; protein.
DR   Bgee; ENSG00000171403; Expressed in penis and 52 other tissues.
DR   ExpressionAtlas; P35527; baseline and differential.
DR   Genevisible; P35527; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:0045095; C:keratin filament; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc.
DR   GO; GO:0008544; P:epidermis development; TAS:ProtInc.
DR   GO; GO:0030855; P:epithelial cell differentiation; IBA:GO_Central.
DR   GO; GO:0045109; P:intermediate filament organization; IMP:UniProtKB.
DR   GO; GO:0043588; P:skin development; IDA:UniProtKB.
DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.
DR   Gene3D; 1.20.5.170; -; 1.
DR   Gene3D; 1.20.5.500; Single helix bin; 1.
DR   Gene3D; 1.20.5.1160; Vasodilator-stimulated phosphoprotein; 1.
DR   InterPro; IPR018039; IF_conserved.
DR   InterPro; IPR039008; IF_rod_dom.
DR   InterPro; IPR002957; Keratin_I.
DR   PANTHER; PTHR23239; INTERMEDIATE FILAMENT; 1.
DR   PANTHER; PTHR23239:SF96; KERATIN, TYPE I CYTOSKELETAL 9; 1.
DR   Pfam; PF00038; Filament; 1.
DR   PRINTS; PR01248; TYPE1KERATIN.
DR   SMART; SM01391; Filament; 1.
DR   SUPFAM; SSF64593; Intermediate filament protein, coiled coil region; 2.
DR   PROSITE; PS00226; IF_ROD_1; 1.
DR   PROSITE; PS51842; IF_ROD_2; 1.
PE   1: Evidence at protein level;
KW   Coiled coil; Direct protein sequencing; Disease variant;
KW   Intermediate filament; Keratin; Palmoplantar keratoderma; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN           1..623
FT                   /note="Keratin, type I cytoskeletal 9"
FT                   /id="PRO_0000063640"
FT   DOMAIN          153..465
FT                   /note="IF rod"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01188"
FT   REGION          1..152
FT                   /note="Head"
FT   REGION          1..25
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          153..188
FT                   /note="Coil 1A"
FT   REGION          189..207
FT                   /note="Linker 1"
FT   REGION          208..299
FT                   /note="Coil 1B"
FT   REGION          300..322
FT                   /note="Linker 12"
FT   REGION          323..461
FT                   /note="Coil 2"
FT   REGION          462..623
FT                   /note="Tail"
FT   REGION          462..496
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          534..623
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         14
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P13645"
FT   MOD_RES         57
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P13645"
FT   VARIANT         157
FT                   /note="M -> K (in EPPK; dbSNP:rs59510579)"
FT                   /evidence="ECO:0000269|PubMed:19874353"
FT                   /id="VAR_071977"
FT   VARIANT         157
FT                   /note="M -> R (in EPPK; dbSNP:rs59510579)"
FT                   /evidence="ECO:0000269|PubMed:16961539"
FT                   /id="VAR_036805"
FT   VARIANT         157
FT                   /note="M -> T (in EPPK; dbSNP:rs59510579)"
FT                   /evidence="ECO:0000269|PubMed:19874353,
FT                   ECO:0000269|PubMed:9856842"
FT                   /id="VAR_010499"
FT   VARIANT         157
FT                   /note="M -> V (in EPPK; dbSNP:rs58597584)"
FT                   /evidence="ECO:0000269|PubMed:12072061,
FT                   ECO:0000269|PubMed:7516304, ECO:0000269|PubMed:9856842"
FT                   /id="VAR_010500"
FT   VARIANT         160
FT                   /note="L -> F (in EPPK; with knuckle pads;
FT                   dbSNP:rs28940896)"
FT                   /evidence="ECO:0000269|PubMed:12838553"
FT                   /id="VAR_035438"
FT   VARIANT         160
FT                   /note="L -> V (in EPPK; dbSNP:rs28940896)"
FT                   /evidence="ECO:0000269|PubMed:9204965"
FT                   /id="VAR_010501"
FT   VARIANT         161
FT                   /note="N -> H (in EPPK; dbSNP:rs59296273)"
FT                   /evidence="ECO:0000269|PubMed:14675368,
FT                   ECO:0000269|PubMed:15115518"
FT                   /id="VAR_036806"
FT   VARIANT         161
FT                   /note="N -> I (in EPPK; dbSNP:rs56707768)"
FT                   /evidence="ECO:0000269|PubMed:12192490,
FT                   ECO:0000269|PubMed:12926810"
FT                   /id="VAR_036807"
FT   VARIANT         161
FT                   /note="N -> K (in EPPK; dbSNP:rs57536312)"
FT                   /evidence="ECO:0000269|PubMed:7512862"
FT                   /id="VAR_003822"
FT   VARIANT         161
FT                   /note="N -> S (in EPPK; dbSNP:rs56707768)"
FT                   /evidence="ECO:0000269|PubMed:14675368,
FT                   ECO:0000269|PubMed:7523529"
FT                   /id="VAR_010502"
FT   VARIANT         161
FT                   /note="N -> Y (in EPPK; dbSNP:rs59296273)"
FT                   /evidence="ECO:0000269|PubMed:7511021"
FT                   /id="VAR_010503"
FT   VARIANT         163
FT                   /note="R -> P (in EPPK; dbSNP:rs57758262)"
FT                   /evidence="ECO:0000269|PubMed:15605275"
FT                   /id="VAR_036808"
FT   VARIANT         163
FT                   /note="R -> Q (in EPPK; dbSNP:rs57758262)"
FT                   /evidence="ECO:0000269|PubMed:10632938,
FT                   ECO:0000269|PubMed:12072061, ECO:0000269|PubMed:19874353,
FT                   ECO:0000269|PubMed:7512862, ECO:0000269|PubMed:8647270,
FT                   ECO:0000269|PubMed:9856842"
FT                   /id="VAR_003823"
FT   VARIANT         163
FT                   /note="R -> W (in EPPK; dbSNP:rs59616921)"
FT                   /evidence="ECO:0000269|PubMed:10844507,
FT                   ECO:0000269|PubMed:12072061, ECO:0000269|PubMed:14675368,
FT                   ECO:0000269|PubMed:7512862, ECO:0000269|PubMed:7532199"
FT                   /id="VAR_003824"
FT   VARIANT         167
FT                   /note="Y -> WL (in EPPK)"
FT                   /id="VAR_036809"
FT   VARIANT         168
FT                   /note="L -> S (in EPPK; dbSNP:rs61157095)"
FT                   /evidence="ECO:0000269|PubMed:7532199"
FT                   /id="VAR_003825"
FT   VARIANT         171
FT                   /note="V -> M (in EPPK; dbSNP:rs57019720)"
FT                   /evidence="ECO:0000269|PubMed:12072061"
FT                   /id="VAR_035439"
FT   VARIANT         172
FT                   /note="Q -> P (in EPPK; dbSNP:rs59878153)"
FT                   /evidence="ECO:0000269|PubMed:7516304"
FT                   /id="VAR_010504"
FT   VARIANT         406
FT                   /note="C -> R (in EPPK; dbSNP:rs77688767)"
FT                   /evidence="ECO:0000269|PubMed:20964665"
FT                   /id="VAR_071978"
FT   VARIANT         454
FT                   /note="Y -> H (in EPPK; dbSNP:rs267607420)"
FT                   /evidence="ECO:0000269|PubMed:19874353"
FT                   /id="VAR_071979"
FT   VARIANT         458
FT                   /note="L -> F (in EPPK; dbSNP:rs58120120)"
FT                   /evidence="ECO:0000269|PubMed:16911293"
FT                   /id="VAR_036810"
FT   VARIANT         458
FT                   /note="L -> P (in EPPK)"
FT                   /evidence="ECO:0000269|PubMed:21715251"
FT                   /id="VAR_071980"
FT   MUTAGEN         163
FT                   /note="R->QHA: Leads to aggregate formation."
FT                   /evidence="ECO:0000269|PubMed:10218578"
FT   CONFLICT        12..13
FT                   /note="SR -> T (in Ref. 1; AAC60619 and 2; CAA52924)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        41
FT                   /note="G -> R (in Ref. 1; AAC60619/CAA82315 and 2;
FT                   CAA52924)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        134
FT                   /note="F -> L (in Ref. 1; AAC60619/CAA82315 and 2;
FT                   CAA52924)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        157..170
FT                   /note="MQELNSRLASYLDK -> HLGAGSTPITASQP (in Ref. 6;
FT                   AAI21171)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   623 AA;  62064 MW;  45C833749B63873D CRC64;
     MSCRQFSSSY LSRSGGGGGG GLGSGGSIRS SYSRFSSSGG GGGGGRFSSS SGYGGGSSRV
     CGRGGGGSFG YSYGGGSGGG FSASSLGGGF GGGSRGFGGA SGGGYSSSGG FGGGFGGGSG
     GGFGGGYGSG FGGFGGFGGG AGGGDGGILT ANEKSTMQEL NSRLASYLDK VQALEEANND
     LENKIQDWYD KKGPAAIQKN YSPYYNTIDD LKDQIVDLTV GNNKTLLDID NTRMTLDDFR
     IKFEMEQNLR QGVDADINGL RQVLDNLTME KSDLEMQYET LQEELMALKK NHKEEMSQLT
     GQNSGDVNVE INVAPGKDLT KTLNDMRQEY EQLIAKNRKD IENQYETQIT QIEHEVSSSG
     QEVQSSAKEV TQLRHGVQEL EIELQSQLSK KAALEKSLED TKNRYCGQLQ MIQEQISNLE
     AQITDVRQEI ECQNQEYSLL LSIKMRLEKE IETYHNLLEG GQEDFESSGA GKIGLGGRGG
     SGGSYGRGSR GGSGGSYGGG GSGGGYGGGS GSRGGSGGSY GGGSGSGGGS GGGYGGGSGG
     GHSGGSGGGH SGGSGGNYGG GSGSGGGSGG GYGGGSGSRG GSGGSHGGGS GFGGESGGSY
     GGGEEASGSG GGYGGGSGKS SHS
//
